Seminar: «Current topics in Pharmacology and Theranostics»

Seminarraum INO-F 703, Institut für Pharmakologie

Datum Zeit Name   Titel Gastgeber 
Feb 6, 2019  12:15  Prof. Dr. De Virgilio Claudio, Department of Biology, University of Fribourg Regulation of TORC1 by Amino Acids: a Central Role for Rag GTPases Within the EGO Complex H.- U. Simon 
Feb 8, 2019 12:15  Prof. Dr. Véronique Witko-Sarsat, PhD, Directeur de Recherche, Institut Cochin, Département Immunologie-Infection-Inflammation, Paris Proliferating Cell Nuclear Antigen: a key regulator of neutrophil survival and activation H.- U. Simon  
Mar 13, 2019 12:15  Prof. Dr. Thierry Hennet, Universität Zürich Prebiotic and immunoregulatory functions of milk oligosaccharides S. von Gunten
Apr 10, 2019 12:15  Prof. Dr. Curzio Ruegg, Department of Oncology, Microbiology and Immunology, University of Fribourg Chemotherapy induced breast cancer dormancy : a new function for old drugs? G. Konstantinidou
Apr 23, 2019 13:15 Prof. Dr. Deborah Keogh-Stroka, Department for BioMedical Research (DBMR), University of Bern PKM2 and macrophage polarization during liver regeneration H.- U. Simon 
Apr 24, 2019 12:15  Prof. Dr. Mirjam Schenk, Institute of Pathology, University of Bern IL32: a treatment to convert tumors from “cold” to “hot” S. von Gunten 
May 1, 2019 12:15 Prof. Dr. Carsten Riether, Department for BioMedical Research (DBMR), University of Bern Immune control of cancer stem cells H.- U. Simon   
May 3, 2019 12:15  Prof. Dr. Peter Ruth, Institut für Pharmazie, Universität Tübingen Cysteine-rich protein 4-negative mice: amplified pathogenic actions of angiotensin II in the heart H.- U. Simon   
May 7, 2019  16:00  Prof. Dr. Lutz Nolte, Vizerektorat Forschung, Universität Bern Swiss Federal Innovation Promotion Instruments H.- U. Simon
May 22, 2019 12:15 Prof. Dr. Christian Widmann, Department of Physiology, University of Lausanne Cell-permeable peptides enter cells in multiple (and unusual) ways G. Konstantinidou 
May 27, 2019 17:10  Prof. Dr. Bruce Carleton, Department of Pediatrics, University of British Columbia Using Pharmacogenomics to Explore the Variability in Response to Drugs U. Amstutz
May 28, 2019 17:15 Prof. Dr. med. David Spirk, Sanofi-Aventis (Suisse) SA and Institute of Pharmacology University of Bern Inaugural Lecture ‘Titularprofessor’ PCSK-9 Inhibition: Reset of Atherosclerosis? D.Spirk 
June 5, 2019  12:15 PD Dr. Manuela Funke-Chambour, Leitende Ärztin, Universitätsklinik für Pneumologie, Inselspital Bern Search for new antifibrotic drugs A. Huwiler
June 12, 2019 12:15 PhD, Masoodi, Pharm. D, Institut für klinische Chemie, Inselspital Bern Investigating the role of lipid metabolism: From Patient phenotyping to personalized treatment A. Huwiler
June 19, 2019 12:15 Prof. Dr. Howard Riezman, Department of Biochemistry, University of Geneva Novel approaches to study lipid homeostasis and function in physiology G. Konstantinidou 
June 26, 2019 12:15 Prof. Dr. Jean-claude Martinou, University of Geneva To be announced G. Konstantinidou
Oct 16, 2019  12:15  Prof. Dr. Jörg Huwyler, Dept. of Pharmacy, Pharmaceutical Technologies, University of Basel Drug targeting to hepatocytes A. Huwiler
Oct 23, 2019 12:15 Dr. Pedro Henrique Imenez Silva, Institute of Physiology University of Zürich The role of proton-activated GPCRs in kidney disease A. Huwiler

Unterstützt durch:

Astellas Pharma AG, Wallisellen

AstraZeneca AG, Baar

Weitere potentielle Sponsoren melden sich bitte bei Prof. Simon